Xiaoxiao Liu (Wenlin Tai)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Epidermal Growth Factor Receptor

Endoplasmic Reticulum Stress

Top Venues

Medical oncology (Northwood, London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Muli Xu, Jiankun Yu, Xiaoxiao Liu, Wanting Jia, Yu Duan, Di Ma, Jiaxuan Ma, Wanyang Lei, Xiaoxiao Liu
METTL3 regulatory TROAP can regulate the progression of non-small cell lung cancer through PI3K/AKT and EMT signaling pathway. Medical oncology (Northwood, London, England) 40 (9) (2023)
Xiaoxiao Liu, Muli Xu, Wanting Jia, Yu Duan, Jiaxuan Ma, Wenlin Tai
PU.1 negatively regulates tumorigenesis in non-small-cell lung cancer. Medical oncology (Northwood, London, England) 40 (2) (2023)
Xiaoxiao Liu, Muli Xu, Wanting Jia, Yu Duan, Jiaxuan Ma, Wenlin Tai
PU.1 negatively regulates tumorigenesis in non-small-cell lung cancer. Medical oncology (Northwood, London, England) 40 (2) (2023)
Xiaoxiao Liu, Muli Xu, Wanting Jia, Yu Duan, Jiaxuan Ma, Wenlin Tai
PU.1 negatively regulates tumorigenesis in non-small-cell lung cancer. Medical oncology (Northwood, London, England) 40 (2) (2023)
Xiaoxiao Liu, Muli Xu, Wanting Jia, Yu Duan, Jiaxuan Ma, Wenlin Tai
PU.1 negatively regulates tumorigenesis in non-small-cell lung cancer. Medical oncology (Northwood, London, England) 40 (2) (2023)